Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial - Park, SJ; Ahn, JM; Kang, DY; PREVENT Investigators (Lancet, 2024)